In a major change to the management of patients with mild asthma, the Global Initiative for Asthma (GINA) has recommended against starting any patients with asthma on short-acting β2 agonist (SABA) relievers alone. Instead, GINA recommends that all adults and adolescents from 12 years are treated with a more equal focus on symptom relief and ...
GINA: time to take mild asthma seriously
By Mardi Chapman
14 May 2019